AZARGA Transition Study in Taiwan for Patients With Uncontrolled Intraocular Pressure
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- First Posted Date
- 2011-12-05
- Last Posted Date
- 2013-05-01
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 74
- Registration Number
- NCT01484951
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
In Vivo Measurement of Corneal Epithelial Changes in Dry Eye Patients
Not Applicable
Completed
- Conditions
- Dry Eye Syndrome
- Interventions
- Other: SYSTANE® Gel Drop lubricant eye gel
- First Posted Date
- 2011-12-02
- Last Posted Date
- 2016-11-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 19
- Registration Number
- NCT01483989
Efficacy and Safety of AL-4943A Ophthalmic Solution in Patients With Allergic Conjunctivitis Using the Conjunctival Allergen Challenge (CAC) Model
Phase 3
Completed
- Conditions
- Allergic Conjunctivitis
- Interventions
- Drug: AL-4943A ophthalmic solutionDrug: AL-4943A vehicle
- First Posted Date
- 2011-11-24
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 397
- Registration Number
- NCT01479374
Lens Wearing Experience and Biocompatibility of a Multi-Purpose Disinfecting Solution (MPDS)
Not Applicable
Completed
- Conditions
- Healthy
- Interventions
- Device: OPTI-FREE PureMoist multipurpose disinfecting solution
- First Posted Date
- 2011-11-22
- Last Posted Date
- 2012-11-19
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 125
- Registration Number
- NCT01476722
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Patient Preference Comparison of AZARGA Versus COSOPT in Patients With Glaucoma
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- Drug: Brinzolamide/Timolol Maleate Fixed Combination (AZARGA)Drug: Dorzolamide/timolol Maleate Fixed Combination (COSOPT)
- First Posted Date
- 2011-11-15
- Last Posted Date
- 2016-11-21
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 120
- Registration Number
- NCT01471158
- Locations
- 🇦🇷
Centro Oftalmológico, Buenos Aires, Argentina
Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)
Phase 4
Completed
- Conditions
- GlaucomaOcular HypertensionOpen-Angle Glaucoma
- Interventions
- First Posted Date
- 2011-11-03
- Last Posted Date
- 2013-09-13
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 84
- Registration Number
- NCT01464424
Safety and Efficacy of AL-53817 Nasal Spray Solution
Phase 1
Completed
- Conditions
- Nasal AllergiesAllergies
- Interventions
- Drug: AL-53817 nasal spray solutionOther: Vehicle nasal spray
- First Posted Date
- 2011-10-19
- Last Posted Date
- 2013-05-20
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 110
- Registration Number
- NCT01454505
- Locations
- 🇺🇸
Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
Travoprost 3-Month Safety and Efficacy Study
Phase 3
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-10-18
- Last Posted Date
- 2013-10-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 1099
- Registration Number
- NCT01453855
Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%
Phase 3
Withdrawn
- Conditions
- Open Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-10-14
- Last Posted Date
- 2012-02-10
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT01452009
A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
Phase 2
Completed
- Conditions
- Open-Angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2011-09-01
- Last Posted Date
- 2013-07-08
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 103
- Registration Number
- NCT01426867
© Copyright 2025. All Rights Reserved by MedPath